NCT00010413View on ClinicalTrials.gov

Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus

PHASE2CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

August 31, 2007

Conditions

Pemphigus

Interventions

DRUG

cyclophosphamide

DRUG

filgrastim

Trial Locations (1)

21205

Johns Hopkins University School of Medicine, Baltimore

All Listed Sponsors

lead

Johns Hopkins University

OTHER